You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • OP0088 Discovery of a novel anti-bone resorption compound, AS2690168, which inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappa B ligand (RANKL)

Alerts

Article menu
Download PDFPDF
Scientific Abstracts
Oral Presentations
Abstract Session: Early pathogenic mechanisms; clues for targeted therapies in arthritis
OP0088 Discovery of a novel anti-bone resorption compound, AS2690168, which inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappa B ligand (RANKL)
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address